The Effect of Lyophilized and Frozen Umbilical Cord Cryoextract on L929 Cell Culture
DOI:
https://doi.org/10.20535/ibb.2025.9.1.313718Abstract
Background. The human umbilical cord is a promising source of biologically active substances with regenerative properties. However, the potential of lyophilized cryoextract from the umbilical cord for regenerative medicine, which could facilitate storage and transportation, remains unexplored. Therefore, it is important to study the effect of such cryoextracts using a cellular model.
Objective. To evaluate the effect of lyophilized and frozen umbilical cord cryoextracts on the L929 cell line to assess their therapeutic potential.
Methods. This study was conducted on L929 cell cultures. Cryoextracts from the human umbilical cord were obtained through cryoextraction and lyophilized forms at -80 and -20 °C. These extracts were added to Dulbecco's Modified Eagle Medium (DMEM) at three concentrations: 0.1, 0.5, and 1.0 mg/ml. The control groups included cells cultured in DMEM with and without fetal bovine serum. Cell morphology and monolayer confluency were observed. To assess the impact of the cryoextracts, several assays were performed: cell viability (adhesion), migration activity (scratch test), pinocytosis activity (neutral red uptake assay), metabolic activity (MTT assay), and (proliferation) population doubling time.
Results. The addition of umbilical cord cryoextract and its lyophilized form at -80 °C was non-toxic to the cells. The most effective concentration was 0.1 mg/ml, which significantly stimulated cell adhesion and proliferation compared to the culture medium without fetal serum. The lyophilized cryoextract at -20 °C did not enhance cell viability but did increase pinocytosis activity.
Conclusions. These findings suggest that umbilical cord cryoextract and its lyophilized form at -80 °C can be used as growth factors in cell line cultivation. The lyophilized cryoextract shows promise for use in conditions where specialized storage equipment is not available. However, the lyophilized form at -20 °C primarily stimulates pinocytosis activity and inhibits proliferation.
References
Fathi AH, Soltanian H, Saber AA. Surgical anatomy and morphologic variations of umbilical structures. The American Surgeon™. 2012;78(5):540-4. DOI: 10.1177/000313481207800534
Davies JE, Walker JT, Keating A. Concise review: Wharton's jelly: the rich, but enigmatic, source of mesenchymal stromal cells. Stem Cells Translational Medicine. 2017;6(7):1620-30. DOI: 10.1002/sctm.16-0492
Basta M, Lipsett BJ. Anatomy, abdomen and pelvis: umbilical cord. StatPearls, 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK557389/
Li W, Ye B, Cai X-Y, Lin J-H, Gao W-Q. Differentiation of human umbilical cord mesenchymal stem cells into prostate-like epithelial cells in vivo. PLoS One. 2014;9(7):e102657. DOI: 10.1371/journal.pone.0102657
Chen K-H, Shao P-L, Li Y-C, Chiang JY, Sung P-H, Chien H-W, et al. Human umbilical cord-derived mesenchymal stem cell therapy effectively protected the brain architecture and neurological function in rat after acute traumatic brain injury. Cell Transplantation. 2020;29:963689720929313. DOI: 10.1177/0963689720929313
Mushahary D, Spittler A, Kasper C, Weber V, Charwat V. Isolation, cultivation, and characterization of human mesenchymal stem cells. Cytometry Part A. 2018;93(1):19-31. DOI: 10.1002/cyto.a.23242
Hong B, Lee S, Shin N, Ko Y, Kim D, Lee J, Lee W. Bone regeneration with umbilical cord blood mesenchymal stem cells in femoral defects of ovariectomized rats. Osteoporosis and Sarcopenia. 2018;4(3):95-101. DOI: 10.1016/j.afos.2018.08.003
Sun X, Hao H, Han Q, Song X, Liu J, Dong L, Han W, Mu Y. Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats. Stem Cell Research & Therapy. 2017;8(1):241. DOI: 10.1186/s13287-017-0668-1
Chez M, Lepage C, Parise C, Dang-Chu A, Hankins A, Carroll M. Safety and observations from a placebo-controlled, crossover study to assess use of autologous umbilical cord blood stem cells to improve symptoms in children with autism. Stem Cells Translational Medicine. 2018;7(4):333-41. DOI: 10.1002/sctm.17-0042
Galieva LR, Mukhamedshina YO, Arkhipova SS, Rizvanov AA. Human umbilical cord blood cell transplantation in neuroregenerative strategies. Frontiers in Pharmacology. 2017;8:628. DOI: 10.3389/fphar.2017.00628
Ward KR, Matejtschuk P. The principles of freeze-drying and application of analytical technologies. In: Cryopreservation and Freeze-Drying Protocols, vol. 2180. New York, NY: Springer US, 2021, pp. 99-127. DOI: 10.1007/978-1-0716-0783-1_3
Akers MJ. Basic principles of lyophilization, Part 1. International Journal of Pharmaceutical Compounding. 2015;19(6):471-6.
Bullard JD, Lei J, Lim JJ, Massee M, Fallon AM, Koob TJ. Evaluation of dehydrated human umbilical cord biological properties for wound care and soft tissue healing. Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2019;107(4):1035-46. DOI: 10.1002/jbm.b.34196
Couture M. A single-center, retrospective study of cryopreserved umbilical cord for wound healing in patients suffering from chronic wounds of the foot and ankle. Wounds. 2016;28(7):217-25.
Liu Q, Barragan HR, Matcham G. Umbilical cord biomaterial for medical use. WO patent WO2008021391A1, published 21.02.2008. Available from: https://patents.google.com/patent/WO2008021391A1/en?oq=WO2008021391A1
Kim S-M, Moon S-H, Lee Y, Kim GJ, Chung H-M, Choi Y-S. Alternative xeno-free biomaterials derived from human umbilical cord for the self-renewal ex-vivo expansion of mesenchymal stem cells. Stem Cells and Development. 2013;22(22):3025-38. DOI: 10.1089/scd.2013.0067
Yildiz H, Sen E, Dalcik H, Meseli SE. Evaluation of cell morphology and adhesion capacity of human gingival fibroblasts on titanium discs with different roughened surfaces: an in vitro scanning electron microscope analysis and cell culture study. Folia Morphologica. 2023;82(1):63-71. DOI: 10.5603/FM.a2022.0072
Hulkower KI, Herber RL. Cell migration and invasion assays as tools for drug discovery. Pharmaceutics. 2011;3(1):107-24. DOI: 10.3390/pharmaceutics3010107
Repetto G, del Peso A, Zurita JL. Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nature Protocols. 2008;3(7):1125-31. DOI: 10.1038/nprot.2008.75
Culenova M, Nicodemou A, Novakova ZV, Debreova M, Smolinská V, Bernatova S, et al. Isolation, culture and comprehensive characterization of biological properties of human urine-derived stem cells. International Journal of Molecular Sciences. 2021;22(22):12503. DOI: 10.3390/ijms222212503
Priyadarshini P, Samuel S, Kurkalli BG, Kumar C, Kumar BM, Shetty N, et al. In vitro comparison of adipogenic differentiation in human adipose-derived stem cells cultured with collagen gel and platelet-rich fibrin. Indian Journal of Plastic Surgery. 2021;54(3):278-83. DOI: 10.1055/s-0041-1733810
Sukhodub L, Kumeda M, Sukhodub L, Tsyndrenko O, Petrenko O, Prokopiuk V, Tkachenko A. The effect of carbon and magnetic nanoparticles on the properties of chitosan-based neural tubes: Cytotoxicity, drug release, In Vivo nerve regeneration. Carbohydrate Polymer Technologies and Applications. 2024;8:100528. DOI: 10.1016/j.carpta.2024.100528
Romanov YA, Svintsitskaya VA, Smirnov VN. Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells. 2003;21(1):105-10. DOI: 10.1634/stemcells.21-1-105
Velarde F, Castañeda V, Morales E, Ortega M, Ocaña E, Álvarez-Barreto J, et al. Use of human umbilical cord and its byproducts in tissue regeneration. Frontiers in Bioengineering and Biotechnology. 2020;8:117. DOI: 10.3389/fbioe.2020.00117
Raphael A. A single-centre, retrospective study of cryopreserved umbilical cord/amniotic membrane tissue for the treatment of diabetic foot ulcers. Journal of Wound Care. 2016;25(Sup7):S10-S17. DOI: 10.12968/jowc.2016.25.Sup7.S10
Chang H-K, Lo W-Y. Cryopreservation of umbilical cord tissue for cord tissue-derived stem cells. Patent of United States US8703411B2, published 22.04.2014. Available from: https://patents.google.com/patent/US8703411B2/en
Caputo WJ, Vaquero C, Monterosa A, Monterosa P, Johnson E, Beggs D, Fahoury GJ. A retrospective study of cryopreserved umbilical cord as an adjunctive therapy to promote the healing of chronic, complex foot ulcers with underlying osteomyelitis. Wound Repair and Regeneration. 2016;24(5):885-93. DOI: 10.1111/wrr.12456
Raphael A, Gonzales J. Use of cryopreserved umbilical cord with negative pressure wound therapy for complex diabetic ulcers with osteomyelitis. Journal of Wound Care. 2017;26(Sup10):S38-S44. DOI: 10.12968/jowc.2017.26.Sup10.S38
Everett E, Mathioudakis N. Update on management of diabetic foot ulcers. Annals of the New York Academy of Sciences. 2018;1411(1):153-65. DOI: 10.1111/nyas.13569
Marston WA, Lantis JC, Wu SC, Nouvong A, Lee TD, McCoy ND, et al. An open-label trial of cryopreserved human umbilical cord in the treatment of complex diabetic foot ulcers complicated by osteomyelitis. Wound Repair and Regeneration. 2019;27(6):680-6. DOI: 10.1111/wrr.12754
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 The Author(s)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The ownership of copyright remains with the Authors.
Authors may use their own material in other publications provided that the Journal is acknowledged as the original place of publication and National Technical University of Ukraine “Igor Sikorsky Kyiv Polytechnic Institute” as the Publisher.
Authors are reminded that it is their responsibility to comply with copyright laws. It is essential to ensure that no part of the text or illustrations have appeared or are due to appear in other publications, without prior permission from the copyright holder.
IBB articles are published under Creative Commons licence:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under CC BY 4.0 that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
